alexa
Reach Us +441474556909
Editor - Esam Z. Dajani | Loyola University | 24743
ISSN: 2577-0543

Journal of Formulation Science & Bioavailability
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Esam Z. Dajani

Esam Z. Dajani
Esam Z. Dajani
Adjunct Professor of medicine
Loyola university, Chicago
Loyola University

Biography

Professor Esam Z. Dajani, Ph.D., FACG is the founder and president of International Drug Development Consultants (IDDC) Corporation, a Contract Research Organization (CRO) which provides scientific consulting services to pharmaceutical companies, law firms and governmental agencies. The scope of the consulting service includes clinical pharmacology, toxicology, drug development and regulatory affairs. He has directed worldwide clinical research and development at major pharmaceutical companies. He led the research teams that discovered and developed misoprostol (Cytotec), an anti-ulcer drug. Since 1980, he held continuous academic appointments in pharmacology and in medicine. He is currently serving as Adjunct Professor of Medicine at Loyola University-Chicago. He taught pharmacology and toxicology to medical, dental and pharmacy students. He has research interests in clinical pharmacology, gastrointestinal pharmacology, central nervous system pharmacology, prostaglandins, non-steroidal anti-inflammatory drugs (NSAIDs), growth hormones (e.g., epidermal growth factor), cannabinoids and narcotic analgesics.

Research Interest

clinical pharmacology, gastrointestinal pharmacology, central nervous system pharmacology, prostaglandins, non-steroidal anti-inflammatory drugs (NSAIDs), growth hormones (e.g., epidermal growth factor), cannabinoids and narcotic analgesics.

Top